NCT05669326 2025-12-03
NODDI-TRACT
GCS Ramsay Santé pour l'Enseignement et la Recherche
Phase NA Withdrawn
Clinical Trials
85 trialsNCT06776406 2025-11-25
Head Stabilization in Whole Brain RT
Abramson Cancer Center at Penn Medicine
Phase NA Withdrawn
NCT05904704 2025-11-14
Oxygen-Enhanced MRI for Generating Hypoxia Maps in Patients With Intracranial Tumors
OHSU Knight Cancer Institute
Phase NA Withdrawn
NCT05341947 2025-10-22
Activated Autologous T Cells Against Glioma Cancer Stem Cell Antigens for Patients With Recurrent Glioblastoma
Cedars-Sinai Medical Center
Phase 1 Withdrawn
NCT05789862 2025-08-29
Behavioral Health Evaluation and Intervention Program for Patients Undergoing Craniotomy
University of California, San Francisco
Phase NA Withdrawn
NCT07046481 2025-07-01
Physical Activity and Quality of Life in Childhood Cancersurvivors- a Long-term Follow-up
Region Skane
Phase NA Withdrawn
NCT05620914 2025-06-15
PARAMETer
Duke University
Phase 2 Withdrawn
NCT06494046 2025-06-04
Defining Musical Toxicity and Its Effect on Patient Well-being
Mayo Clinic
Withdrawn
NCT05840770 2025-05-26
Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer
City of Hope Medical Center
Phase 2 Withdrawn
NCT02145910 2025-05-02
Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases
Thomas Jefferson University
Phase 1 Withdrawn
NCT05516485 2025-03-04
Measuring Brain Tumor Consistency Using Magnetic Resonance Elastography
University of Southern California
Phase NA Withdrawn
NCT06075615 2025-02-07
A Study to Learn About Dacomitnib in Patients With Non-small Cell Lung Cancer Which Has Spread to the Brain.
Pfizer
Withdrawn
NCT04521946 2024-10-26
Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT03925675 2024-09-03
18F-Fluciclovine PET and Multiparametric MR Imaging
Loma Linda University
Phase 2 Withdrawn
NCT05999357 2024-05-29
STRIDER
Maastricht University Medical Center
Phase 2 Withdrawn
NCT03955068 2024-05-22
Strict Classic Ketogenic Diet as a Therapy for Recurrent or Progressive and Refractory Brain Tumors in Children
University of Texas Southwestern Medical Center
Phase NA Withdrawn
NCT05120960 2024-04-17
A Phase 1a/1b Study to Determine the Recommended Phase 2 Dose, of Tepotinib in Participants With MET Alterations and Brain Tumors
M.D. Anderson Cancer Center
Phase 1 Withdrawn
NCT06137651 2024-04-01
Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis
Northwestern University
Phase 1 Withdrawn
NCT04019470 2024-02-07
Immunomodulation Analysis of Radiation Therapy in Pediatric Malignant Brain Tumors
Capital Medical University
Withdrawn
NCT04344626 2023-10-10
Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery
University of California, Los Angeles
Phase NA Withdrawn
NCT03803761 2023-09-25
A Study of a New Drug Combination, Copanlisib and Fulvestrant, in Advanced Breast Cancer
National Cancer Institute (NCI)
Phase 1/2 Withdrawn
NCT05054400 2023-09-01
Study of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT04427228 2023-08-28
MIGRAINE
University of Chicago
Phase 2 Withdrawn
NCT05255666 2023-07-11
Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)
Washington University School of Medicine
Phase 2 Withdrawn
NCT04650490 2023-03-02
STICk-IM-NSCLC
Duke University
Phase 2 Withdrawn
NCT00555711 2022-10-20
MI
University of California, Irvine
Withdrawn
NCT04776980 2022-09-16
Multimodality MRI and Liquid Biopsy in GBM
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Withdrawn
NCT04200066 2022-08-22
A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
University of Rochester
Phase 1 Withdrawn
NCT02201381 2022-07-18
METRICS
Health Clinics Limited
Phase 3 Withdrawn
NCT04512261 2022-07-01
TOPAZ
Cedars-Sinai Medical Center
Phase 1/2 Withdrawn
NCT04856475 2022-03-02
NeraBrain
Jules Bordet Institute
Phase 2 Withdrawn
NCT05247749 2022-02-21
CONVIVO System to Discriminate Healthy Tissues vs Tumor Tissues During Brain Tumor Resection
Stanford University
Phase NA Withdrawn
NCT03868423 2022-02-18
Brigatinib in Treating Patients With ALK and ROS1 Gene Alterations and Locally Advanced or Metastatic Solid Cancers
Ohio State University Comprehensive Cancer Center
Phase 2 Withdrawn
NCT04069910 2022-01-31
Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain Metastases
Jonsson Comprehensive Cancer Center
Phase NA Withdrawn
NCT02567643 2022-01-11
Stereotactic Radiosurgery (SRS) for Multiple CNS Mets
The Cooper Health System
Phase NA Withdrawn
NCT04585724 2021-10-18
Stereotactic Radiosurgery With Abemaciclib, Ribociclib, or Palbociclib in Treating Patients With Hormone Receptor Positive Breast Cancer With Brain Metastases
Emory University
Phase 1 Withdrawn
NCT03091803 2021-04-05
QSM and Regional DCE MRI Permeability Using GOCART Technique
University of Southern California
Withdrawn
NCT03177252 2020-10-22
Scalp block
Washington University School of Medicine
Phase 1 Withdrawn
NCT00836628 2020-08-05
Study of Busulfan for Refractory Central Nervous System (CNS) Tumors
Ann & Robert H Lurie Children's Hospital of Chicago
Phase 1 Withdrawn
NCT03629964 2020-05-08
Study to Develop Head Stabilizer for Use During Brain Radiation Therapy
University of Chicago
Phase NA Withdrawn
NCT03637868 2020-05-06
ERIBRAIN
Institut Paoli-Calmettes
Phase 2 Withdrawn
NCT02277561 2020-03-04
Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery
Albert Einstein College of Medicine
Phase NA Withdrawn
NCT01117155 2019-12-12
A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
National Institutes of Health Clinical Center (CC)
Withdrawn
NCT01202539 2019-10-03
Real-time Assessment of Frameless Intrafraction Motion
Oregon Health and Science University
Withdrawn
NCT00977795 2019-09-10
A Study of the Specificity and Sensitivity of 5-ALA Fluorescence in Malignant Brain Tumors
Endeavor Health
Phase 1/2 Withdrawn
NCT01212237 2019-07-29
Dose Response of Functionally Critical Brain Regions for Brain Radiotherapy
Weill Medical College of Cornell University
Withdrawn
NCT02328300 2018-11-14
FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain Lesions
UNC Lineberger Comprehensive Cancer Center
Withdrawn
NCT03297463 2018-08-01
Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma
Masonic Cancer Center, University of Minnesota
Phase 1/2 Withdrawn
NCT02014545 2018-07-05
Evaluation of Lucanthone to Whole Brain Radiation Therapy in Patients With Brain Metastases From Non-Small Cell Lung Cancer
Wake Forest University Health Sciences
Phase 2 Withdrawn
NCT01736722 2018-01-17
MRI-Guided LITT for Treatment Metastatic Brain Tumors
The Methodist Hospital Research Institute
Phase NA Withdrawn